Homepage
Accelerating CNS drug development through the science of eye movements.
The NeuraLight platform captures eye movements to generate objective biomarkers that support drug development for central nervous system diseases.
Technology
Designed to be implemented in clinical practice
With ease-of-use as a first principle, our platform employs computer vision and machine learning to produce dozens of valuable oculometric measures. With these measures, meaningful clinical insights are delivered on various dimensions of patients’ conditions.
Clinical Partnerships
NeuraLight is a part of multiple clinical partnerships for different CNS diseases conducted in leading medical centers worldwide.
Partnerships
Partner with us to accelerate your CNS drug development
